Zenilac 3.35 gm/5 ml (Oral Solution)
100 ml bottle: ৳ 120.00
Medicine Details
Category | Details |
---|---|
Generic | Lactulose |
Company | Zenith pharmaceuticals ltd |
Title
- Zenilac 3.35 gm/5 ml Oral Solution
Categories
- Medicine
- Healthcare
- Laxative
Description
- Zenilac is a hyperosmolar laxative
- Used for constipation
- Non-absorbable disaccharide
- Draws water into the bowel
- Causes distention through fluid accumulation
- Promotes soft stool and accelerates bowel motion
Indications
- Effective treatment for constipation
- Treatment for chronic constipation
- Diet rich in fiber and liquids as initial treatment
- Treatment of intestinal flora disturbances
- Reduction of blood ammonia levels
Pharmacology
- Synthetic disaccharide
- Metabolized in the colon by saccharolytic bacteria
- Produces low molecular weight organic acids
- Lowers the pH of the colon contents
- Promotes retention of water by osmotic effect
- Increases peristaltic activity
- Minimally absorbed
Dosage and administration
- Adult dosage of 3-6 tea-spoons daily for constipation
- Children dosage of 3 tea-spoons daily for constipation
- Infants and toddlers dosage of 1-2 tea-spoons daily for constipation
- Adult dosage of 1-2 tea-spoons daily for damaged intestinal flora
- Children dosage of 1 tea-spoon daily for damaged intestinal flora
- Maximum dosage of 18-30 tea-spoons daily for reducing blood ammonia levels in hepatopathy
- Hourly doses of 6-9 tea-spoons for inducing rapid laxation in portal systemic encephalopathy
Interaction
- No significant drug interactions
- Intensified glycosidic effect of cardiac glycosides by potassium deficiency in abuse
Contraindications
- Hypersensitivity to galactose and lactose
- Galactose-free diet
- Gastro-cardial symptom complex
- Suspected intestinal obstruction
Side effects
- Flatulence
- Cramp
- Abdominal discomfort
- Rapidly eliminated by reducing the dose
- Overdose can result in diarrhea
- Loss of electrolytes, primarily potassium
Pregnancy and lactation
- US FDA Pregnancy Category B
- No adverse effects reported
- Decisions regarding use during pregnancy and lactation must be made by a registered physician
Precautions and warnings
- Administered with care to patients intolerant to Zenilac
- Higher dose in (pre)coma hepaticum may need to be considered for diabetics
Overdose effects
- No reports of accidental overdosage
- Expected symptoms of acute overdosage: diarrhea and abdominal cramps
Therapeutic class
- Osmotic purgatives
Storage conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children
Chemical structure
- Molecular formula: C12H22O11
- Chemical structure image available
Commonly asked questions
- Use for treating constipation and reducing blood ammonia in liver disease
- Frequency of use for constipation and liver disease
- Time taken to see benefits of treatment
- Usage for constipation symptoms
- Confirmation of Zenilac as a laxative
- Common side effects and their causes
- Duration of use and patients to avoid
- Consequences of taking more than the recommended dose
Additional info
- Available as 3.35 gm/5 ml oral solution
- No reports of significant drug interactions
- Administered in various dosages for different indications
- Suitable for use during pregnancy and lactation
Related Brands
- Xylose 3.35 gm/5 ml (Oral Solution) - delta-pharma-ltd
- Tulos 3.35 gm/5 ml (Oral Solution) - acme-laboratories-ltd
- Tulac 3.35 gm/5 ml (Oral Solution) - eskayef-pharmaceuticals-ltd
- Sivolac 3.35 gm/5 ml (Oral Solution) - sharif-pharmaceuticals-ltd
- Sinalac 3.35 gm/5 ml (Oral Solution) - ibn-sina-pharmaceuticals-ltd